Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
about
Sc65 is a novel endoplasmic reticulum protein that regulates bone mass homeostasisAneuploidy and skeletal health.Determinants of vitamin d levels in children and adolescents with down syndromeDifferential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model.Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.Bone mineral density in adults with Down syndrome.Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a.Co-occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines.Treatment with anti-Sclerostin antibody to stimulate mandibular bone formation.Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
P2860
Q34033354-0B0F25FD-E3D1-47C2-A96E-94F4B5698EB0Q34059928-37A330D0-F670-48EA-85E3-CC40DC6680ECQ35061417-3FE8A390-C55C-46E2-A99F-1D27DBE40565Q36788710-8B62672E-6844-4F89-83C0-DB79E263835DQ37668209-C2A10CD9-4578-4471-BD4B-F069271B21B3Q38690073-83CDB007-6E7E-433C-AD75-834A24279CE4Q50202346-ECC987AD-7C95-4382-A148-DFFE9034431BQ50576290-63A2EBA5-0B9A-48A1-BCAA-B6003B578869Q52438040-79125E8F-37FB-4799-A283-9E4D5DB69709Q52664558-8A4A930D-116D-47F5-8473-D14B7FF664BBQ57150920-78AE6118-0B48-4F6D-BEA7-2047942FB749
P2860
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@ast
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@en
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@nl
type
label
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@ast
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@en
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@nl
prefLabel
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@ast
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@en
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@nl
P2093
P2860
P1433
P1476
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
@en
P2093
Anthony W Bacon
Dana Gaddy
Donna B Leblanc
Frances L Swain
Galen R Wenger
Jaclyn Vander Schilden
John W Bracey
Kent D McKelvey
Nisreen S Akel
Robert A Skinner
P2860
P304
P356
10.1371/JOURNAL.PONE.0042967
P407
P50
P577
2012-01-01T00:00:00Z